Nov 9 (Reuters) - Dynavax Technologies Corp
* Dynavax announces FDA approval of Heplisav-B for prevention of Hepatitis B in adults
* Dynavax Technologies Corp - expects to commercially launch Heplisav-B in United States in Q1 of 2018 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.